These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


120 related items for PubMed ID: 3465872

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison between L-dopa and lisuride intravenous infusions: a clinical study.
    Ruggieri S, Stocchi F, Carta A, Bravi D, Bragoni M, Giorgi L, Agnoli A.
    Mov Disord; 1988; 3(4):313-9. PubMed ID: 3211176
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intravenous lisuride corrects oscillations of motor performance in Parkinson's disease.
    Obeso JA, Luquin MR, Martínez Lage JM.
    Ann Neurol; 1986 Jan; 19(1):31-5. PubMed ID: 3947037
    [Abstract] [Full Text] [Related]

  • 5. Clinical implications of sustained dopaminergic stimulation.
    Stocchi F, Patsalos PN, Berardelli A, Barbato L, Bonamartini A, Manfredi M, Ruggieri S.
    Clin Neuropharmacol; 1994 Jan; 17 Suppl 2():S7-13. PubMed ID: 9358190
    [Abstract] [Full Text] [Related]

  • 6. Chronic s.c. lisuride in Parkinson's disease--motor-performance and avoidance of psychiatric side effects.
    Bittkau S, Przuntek H.
    J Neural Transm Suppl; 1988 Jan; 27():35-54. PubMed ID: 3165438
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Continuous dopaminergic stimulation in the management of complicated Parkinson's disease.
    Agnoli A, Stocchi F, Carta A, Antonini A, Bragoni M, Ruggieri SA.
    Mt Sinai J Med; 1988 Jan; 55(1):62-6. PubMed ID: 3258057
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Lisuride infusion pump: a device for the treatment of motor fluctuations in Parkinson's disease.
    Obeso JA, Luquin MR, Martínez-Lage JM.
    Lancet; 1986 Mar 01; 1(8479):467-70. PubMed ID: 2869209
    [Abstract] [Full Text] [Related]

  • 17. The use of lisuride in severe Parkinson's disease.
    Chin D, Yu YL, Huang CY.
    Clin Exp Neurol; 1986 Mar 01; 22():63-9. PubMed ID: 3581512
    [Abstract] [Full Text] [Related]

  • 18. Treatment of Parkinson's disease with subcutaneous lisuride infusions.
    Fernandez Pardal M, Micheli F, Gatto M, Perez y Gonzalez N.
    J Neural Transm Suppl; 1988 Mar 01; 27():75-84. PubMed ID: 2969954
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.